Boron neutron capture enhancement study for radiation therapy with fast fission neutrons
1Technical University of Munich (TUM), Heinz Maier-Leibnitz Zentrum (MLZ), Lichtenbergstr. 1, Garching, 85748, Germany.
Related Experiment Videos
View abstract on PubMed
Summary
This study explored combining fast neutron therapy (FNT) with boron neutron capture therapy (BNCT) principles. Results show minimal dose enhancement with standard clinical parameters but significant increases with thermal neutron components, suggesting promising avenues for advanced cancer treatment.
Area of Science:
- Medical Physics
- Radiation Oncology
- Nuclear Medicine
Background:
- Fast neutron therapy (FNT) usage has decreased, while boron neutron capture therapy (BNCT) is experiencing a resurgence.
- The MEDAPP facility at FRM II previously used fission neutrons for patient treatment.
Purpose of the Study:
- To investigate enhancing dose deposition in fission-based fast neutron therapy by incorporating boron neutron capture reactions.
- To explore the feasibility of advanced cancer treatment options by combining FNT and BNCT concepts.
Main Methods:
- Monte Carlo simulations were employed to calculate dose rates.
- Simulations were performed in a water phantom with B-10 enriched regions of interest.
- Investigated combinations of clinical FNT neutron spectrum with BNCT-required B-10 concentrations, higher B-10 concentrations, and modified neutron spectra with thermal components.
Main Results:
- The influence of B-10 concentration on dose rate was minimal (<3%) when combined with the clinical FNT spectrum and B-10 concentration.
- A significant increase in dose rate was observed with the addition of a thermal component to the neutron spectrum.
- Physical dose rate enhancement was low for the combination of clinically available FNT and BNCT scenarios.
Conclusions:
- Combining clinically available FNT and BNCT treatment scenarios yields limited dose rate enhancement.
- Exploiting a thermal neutron component within a modified spectrum shows promise for advanced radiotherapy.
- Further research into biological selectivity and thermal neutron exploitation is warranted.